Skip to main content
BA

Biobot Analytics

Biobot Analytics utilizes molecular technologies and AI to analyze wastewater, providing real-time data on population health threats such as viral outbreaks and substance use. This approach enables early detection of health trends, allowing public health officials to allocate resources effectively and implement proactive harm reduction strategies.

Cambridge, United KingdomFounded 2017317K+ followers
Updated 20 months ago

Funding

$27.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

NI
Funding rounds are not available yet.

Founders

Product

Problem

Public health officials often lack timely, comprehensive data on community health threats, hindering effective resource allocation and proactive intervention strategies. Traditional surveillance methods rely on clinical data, which may be delayed, incomplete, and not representative of the entire population. This can lead to delayed responses to outbreaks and inefficient allocation of resources.

Solution

Biobot Analytics provides real-time, population-level insights into health threats by analyzing wastewater using molecular technologies and AI. Their approach enables early detection of viral outbreaks, tracks the prevalence of high-risk drug use, and predicts potential overdose events. By analyzing sewage, Biobot captures data from all members of a community, regardless of healthcare access, providing a more representative and timely view of population health. This data allows public health officials to proactively allocate resources, implement harm reduction strategies, and optimize healthcare interventions.

Target Audience

The primary customers are public health agencies, hospitals, and researchers seeking early warnings of outbreaks, insights into community disease burden, and data to inform resource allocation and intervention strategies.

Features

  • Molecular analysis of wastewater for early detection of viral pathogens (e.g., SARS-CoV-2, influenza, RSV)
  • AI-powered platform for identifying and quantifying substances related to substance use disorder
  • Predictive modeling to forecast disease outbreaks and overdose events
  • Data comparability across time and location due to standardized collection and analysis methods
  • Early warning system that detects viral surges in wastewater up to two weeks before hospital admissions spike
  • Data insights that complement traditional clinical and hospitalization data sources
This profile is AI-generated and may contain inaccuracies.